Divergent Capital — Full Portfolio
6 tracked investments · listed companies and verified rows first
Baton develops AI-powered supply chain management software, including RyderShare, a collaborative logistics platform that provides real-time visibility and exception management for goods in transit across networks.
AI & Machine LearningLogistics & Supply ChainSaaSMiami, US
Chat Joglekar(Founder)in
Co-investors8VC75 & SunnyBloomberg BetaBurst CapitalFJ LabsFluent Ventures+4 more
Bedrock Energy develops drilling technology and data algorithms for designing and installing geothermal borehole fields used for building heating and cooling.
CleantechClimate TechEnergyLos Angeles, US
Silviu Livescu(Executive Officer)inJoselyn Lai(Executive Officer, Director)inJoel Wishkovsky(Executive Officer, Director)
BoardPaul Straub(Director)in
Co-investorsCantos VenturesEnergy Impact PartnersFirst Star VenturesTitanium VenturesToba CapitalWireframe Ventures+4 more
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Ben Woodington(Co-founder & CEO)Elise Jenkins(Co-founder & CTO)
Co-investorsArtesianBlackbird VenturesPossible VenturesSmartGateVCXEIA Venture PartnersTopology Ventures
Hoop is an AI agent that runs subscription cancellation conversations directly inside a brand's helpdesk, capturing cancel reasons and making segment-based save offers that write back to subscription billing tools like Recharge or Skio.
AI & Machine LearningE-commerceSaaSNew York City, US
Brian Schmidt(Founder)Justin Gallagher(Founder)Stella Garber(Founder)
Co-investorsIndex VenturesOrigin VenturesChingona VenturesVenture Guides Management, L.P.Y Combinator
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)
BoardJacob Robinson(Co-founder & CEO)in
Co-investorsArboretum VenturesPsyMed VenturesTMC Venture FundCapital FactoryDolby Family VenturesKdT Ventures+2 more
Wayfinder Bio develops orally available small-molecule medicines that bind to the mRNAs encoding disease-driving proteins to prevent those proteins from being made.
AI & Machine LearningBiotechDeep Tech
Co-investorsNotation CapitalSocial StartsBoxOne VenturesExor Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.